Use of Phenylephrine for Assessment of Mitral Regurgitation Severity
Public ClinicalTrials.gov record NCT04500899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluating the Severity of Mitral Regurgitation Using Phenylephrine During Transesophageal Echocardiography
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study proposes to develop a phenylephrine protocol to be used during transesophageal echocardiography, whereby intravenous phenylephrine would be used to increase afterload with the intent to mimic the awake hemodynamic profile and variation that occurs with normal physical activity. The expectation is to see changes in severity of Mitral Regurgitation (MR) grade with increasing afterload, which in turn can provide more accurate quantification of MR severity to assist in clinical decision making.
Study identification
- NCT ID
- NCT04500899
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2020
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
- Last update posted
- Jul 19, 2025
2020 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Montefiore Medical Center | New York | New York | 10470 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Mitral Regurgitation trials
Other public records listing Mitral Regurgitation. Sorted by last update posted; newest first. Not a recommendation.
- NCT07756398: Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE) Not yet recruiting
- NCT03230747: SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation Active, not recruiting
- NCT07130994: Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US) Not yet recruiting
- NCT04761120: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study Recruiting
- NCT07069673: Abbott Cephea Mitral Valve Disease Registry Recruiting
- NCT04688190: CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04500899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2025 · Synced Jul 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04500899 live on ClinicalTrials.gov.